Literature DB >> 8871942

AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease. Evidence for hippocampal plasticity.

D M Armstrong1, M D Ikonomovic.   

Abstract

Immunocytochemical techniques were employed in order to examine the distribution and relative intensity of immunolabeling of the alpha-amino-3-hydroxy-5-methyl-4-isoaxolepropionate (AMPA) receptor subunits GluR1 and GluR2/3 within the hippocampal formation of patients with Alzheimer disease (AD). Within sectors of the hippocampus that are particularly vulnerable to AD pathology (i.e., CA1, subiculum), we observed a variable loss of GluR1 and GluR2/3 immunolabeling correlating with the extent of cell loss and neurofibrillary pathology. In contrast, in less vulnerable sectors of the hippocampus (i.e., CA2/3, dentate gyrus), the intensity of immunolabeling was markedly increased in AD cases, particularly in the molecular and polymorphic layers of the dentate gyrus. Importantly, these latter regions correspond to termination zones of glutamatergic perforant pathway axons and mossy fiber collaterals, respectively. The increase in immunolabeling within these projection fields is hypothesized to occur in response to the deafferentation of selected glutamatergic pathways, and suggests a critical role for AMPA receptor subunits in hippocampal plasticity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871942     DOI: 10.1007/BF02815205

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  7 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Tiffany J Mellott; Sudha Seshadri; Jan Krzysztof Blusztajn; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease.

Authors:  David M Armstrong; Roxanne Sheffield; Amanda J Mishizen-Eberz; Troy L Carter; Robert A Rissman; Katsuyoshi Mizukami; Milos D Ikonomovic
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

4.  Endophilin2 Interacts with GluA1 to Mediate AMPA Receptor Endocytosis Induced by Oligomeric Amyloid-β.

Authors:  Jifeng Zhang; Yichen Yin; Zhisheng Ji; Zhenbin Cai; Bo Zhao; Jiong Li; Minghui Tan; Guoqing Guo
Journal:  Neural Plast       Date:  2017-07-05       Impact factor: 3.599

5.  iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer's disease.

Authors:  Jason H Y Yeung; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

6.  Advances on the understanding of the origins of synaptic pathology in AD.

Authors:  Pascale Nathalie Lacor
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

7.  Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex.

Authors:  Jason H Y Yeung; Joshua L Walby; Thulani H Palpagama; Clinton Turner; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  Brain Pathol       Date:  2021-07-16       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.